CAPTOPRIL DECREASES STRESS ULCERATION WITHOUT AFFECTING GASTRIC PERFUSION DURING CANINE HEMORRHAGIC-SHOCK

被引:21
作者
CULLEN, JJ
EPHGRAVE, KS
BROADHURST, KA
BOOTH, B
机构
[1] VET ADM MED CTR,HLTH SERV RES & DEV SERV,N LITTLE ROCK,AR
[2] UNIV IOWA,COLL MED,DEPT SURG,IOWA CITY,IA 52242
[3] VET ADM MED CTR,RES SERV,IOWA CITY,IA 52246
关键词
D O I
10.1097/00005373-199407000-00009
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The renin-angiotensin axis has recently been called the source of disproportionate splanchnic vasoconstriction during shock, and blocking this axis decreased gastric stress ulceration during swine cardiogenic shock. The present study tested whether the angiotensin converting enzyme inhibitor captopril would prevent stress ulceration when given after the onset of canine hemorrhagic shock, and whether any detrimental effects would result from enhancing splanchnic perfusion with captopril during hemorrhagic shock. We found that captopril treatment was associated with a decrease in gastric mucosal injury and with a marked decrease in systemic acidosis. Captopril enhanced blood flow to the small intestine, pancreas, liver, and spleen, but not flow to the stomach, during shock. Following the reinfusion of shed blood, the captopril-treated animals had decreased mean blood pressures and increased heart rates compared with untreated animals. We found captopril alleviated the stress ulceration produced by canine hemorrhagic shock, but concluded that the likely mechanism was alleviating systemic acidosis through enhanced perfusion of other viscera rather than a specific enhancement of gastric perfusion.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 26 条
[1]   THE FUNDAMENTAL HEMODYNAMIC MECHANISM UNDERLYING GASTRIC STRESS ULCERATION IN CARDIOGENIC-SHOCK [J].
BAILEY, RW ;
BULKLEY, GB ;
HAMILTON, SR ;
MORRIS, JB ;
HAGLUND, UH ;
MEILAHN, JE .
ANNALS OF SURGERY, 1987, 205 (06) :597-612
[2]  
BELLAMY RF, 1984, CIRC SHOCK, V14, P113
[3]   EFFECT OF GLUCAGON ON GASTROINTESTINAL BLOOD-FLOW OF DOGS IN HYPOVOLEMIC SHOCK [J].
BOND, JH ;
LEVITT, MD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 238 (05) :G434-G439
[4]   CAPTOPRIL - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE HEART-FAILURE [J].
BROGDEN, RN ;
TODD, PA ;
SORKIN, EM .
DRUGS, 1988, 36 (05) :540-600
[5]  
BUCKLEY GB, 1985, SURGERY, V98, P213
[7]  
CHINTALA MS, 1990, CIRC SHOCK, V32, P219
[8]   RENAL, ADRENAL AND VASCULAR CHANGES DURING INHIBITION OF CONVERTING ENZYME WITH CAPTOPRIL [J].
CLAPPISON, BH ;
MILLAR, JA ;
CASLEY, DJ ;
ANDERSON, WP ;
JOHNSTON, CI .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1980, 7 (05) :493-498
[9]  
CULLEN J J, 1989, Current Surgery, V46, P295
[10]  
EPHGRAVE K S, 1987, Current Surgery, V44, P38